306 related articles for article (PubMed ID: 20157247)
1. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice.
Chakravarthy B; Gaudet C; Ménard M; Atkinson T; Brown L; Laferla FM; Armato U; Whitfield J
J Alzheimers Dis; 2010; 19(3):915-25. PubMed ID: 20157247
[TBL] [Abstract][Full Text] [Related]
2. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal membrane-associated p75NTR levels are increased in Alzheimer's disease.
Chakravarthy B; Ménard M; Ito S; Gaudet C; Dal Prà I; Armato U; Whitfield J
J Alzheimers Dis; 2012; 30(3):675-84. PubMed ID: 22451321
[TBL] [Abstract][Full Text] [Related]
4. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
Chiarini A; Dal Pra I; Whitfield JF; Armato U
Ital J Anat Embryol; 2006; 111(4):221-46. PubMed ID: 17385278
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta₁₋₄₂ (Aβ₄₂) up-regulates the expression of sortilin via the p75(NTR)/RhoA signaling pathway.
Saadipour K; Yang M; Lim Y; Georgiou K; Sun Y; Keating D; Liu J; Wang YR; Gai WP; Zhong JH; Wang YJ; Zhou XF
J Neurochem; 2013 Oct; 127(2):152-62. PubMed ID: 23895422
[TBL] [Abstract][Full Text] [Related]
6. Abeta(1-42) stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor.
Sotthibundhu A; Li QX; Thangnipon W; Coulson EJ
Neurobiol Aging; 2009 Dec; 30(12):1975-85. PubMed ID: 18374455
[TBL] [Abstract][Full Text] [Related]
7. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease.
Diarra A; Geetha T; Potter P; Babu JR
Biochem Biophys Res Commun; 2009 Dec; 390(3):352-6. PubMed ID: 19818333
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
9. The p75 neurotrophin receptor is localized to primary cilia in adult murine hippocampal dentate gyrus granule cells.
Chakravarthy B; Gaudet C; Ménard M; Atkinson T; Chiarini A; Dal Prà I; Whitfield J
Biochem Biophys Res Commun; 2010 Oct; 401(3):458-62. PubMed ID: 20875398
[TBL] [Abstract][Full Text] [Related]
10. Involvement of insulin-like growth factor 1 receptor signaling in the amyloid-β peptide oligomers-induced p75 neurotrophin receptor protein expression in mouse hippocampus.
Ito S; Ménard M; Atkinson T; Gaudet C; Brown L; Whitfield J; Chakravarthy B
J Alzheimers Dis; 2012; 31(3):493-506. PubMed ID: 22635104
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the immunostainable length of the hippocampal dentate granule cells' primary cilia in 3xAD-transgenic mice producing human Aβ(1-42) and tau.
Chakravarthy B; Gaudet C; Ménard M; Brown L; Atkinson T; Laferla FM; Ito S; Armato U; Dal Prà I; Whitfield J
Biochem Biophys Res Commun; 2012 Oct; 427(1):218-22. PubMed ID: 22995307
[TBL] [Abstract][Full Text] [Related]
12. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
13. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
[TBL] [Abstract][Full Text] [Related]
14. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
15. Abeta treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry.
Hoerndli FJ; Pelech S; Papassotiropoulos A; Götz J
Eur J Neurosci; 2007 Jul; 26(1):60-72. PubMed ID: 17587323
[TBL] [Abstract][Full Text] [Related]
16. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
17. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
Nakagawa Y; Nakamura M; McIntosh TK; Rodriguez A; Berlin JA; Smith DH; Saatman KE; Raghupathi R; Clemens J; Saido TC; Schmidt ML; Lee VM; Trojanowski JQ
J Comp Neurol; 1999 Aug; 411(3):390-8. PubMed ID: 10413774
[TBL] [Abstract][Full Text] [Related]
18. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
19. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
[TBL] [Abstract][Full Text] [Related]
20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
